CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated SubgroupKristine Aasebø, Halfdan Sørbye|Frontiers in Oncology|2020Cited by 66